Development and evaluation of human-friendly explanations for sepsis early-warning models
Development and evaluation of human-friendly explanations for sepsis early-warning models
批准号:
10546200
负责人:
Wei-Jien Tan
金额:
$25.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2024-07-31
关键词:
Accident and Emergency departmentAddressAgreementAlgorithm DesignAlgorithmsAmericanArchitectureArtificial IntelligenceAttentionAutoimmune DiseasesBeneficenceBioethics ConsultantsCaringChemotherapy-Oncologic ProcedureClinicalCritical CareDataData SetDependenceDevelopmentDiagnosisDiagnosticEthicsEvaluationExpert OpinionGoalsHealthHomeHospitalsHourHumanImmunocompromised HostIndividualLeadLongitudinal StudiesMapsMeasuresMethodsModelingMonitorNonmaleficenceOncologyOrgan TransplantationOutpatientsOutputPatient CarePatient MonitoringPatient RepresentativePatientsPerformancePhasePhysiciansPublishingRiskSamplingScoring MethodSepsisSepsis SyndromeTechnologyTestingTimeTransplantation SurgeryValidationVisualizationartificial intelligence algorithmbaseclinical decision-makingdeep learning algorithmdisorder riskgraphical user interfacehigh riskhuman dataimprovedinnovationmachine learning algorithmmonitoring devicemortalityneural networkpatient populationprediction algorithmpreventprogramspublic databaserisk predictionseptic patientssuccesstime usewearable device
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this Phase I project is to render a proprietary artificial intelligence algorithm for sepsis
prediction developed by Patchd, Inc., compatible with explainability capabilities, providing clinicians underlying
reasons for increased disease risk, as opposed to a “black box” risk prediction alone. The algorithm is
additionally innovative in that it imputes sepsis risk based on vital sign data gathered from wearable devices,
providing constant real-time surveillance of high-risk patients at home without requiring in-patient monitoring.
Sepsis has a high mortality rate of approximately 40% and often occurs in immunocompromised patients such
as those undergoing cancer chemotherapy, organ transplant surgery, or treatment for autoimmune conditions.
Catching the condition early remains the best way to reduce mortality as well as prevent the long-term health
effects associated with post-sepsis syndrome, which occurs in up to 50% of sepsis patients. Artificial intelligence
(AI) represents an intriguing means of identifying sepsis early. By compiling vital sign data from high-risk patients
and analyzing any changes in real-time, machine learning algorithms have shown promise in identifying at-risk
patients up to 8 hours before sepsis onset in hospital settings. While these predictive algorithms demonstrate
the power of AI in patient monitoring, most high-risk patients are treated via out-patient care without constant
vital sign monitoring. Patchd, Inc. has developed an AI algorithm for sepsis prediction which employs vital sign
data generated using wearable devices, such as watches or patches which record patient data in real-time. Thus
far, the algorithm has been shown to improve sepsis prediction accuracy and provide earlier warnings for sepsis
onset compared to other scoring methods. Recently however, bioethicists and regulators have called for AI
algorithms to pair their predictions with supporting explanatory information providing both clinicians and patients
more transparency when considering treatment options. During this Phase I program, Patchd will employ its
current algorithm architecture and add so-called explainability functions, revealing to the user which specific vital
sign dynamics impacted a given prediction. Vital sign data will be analyzed for local explanation functionality
using both kernel and deep SHapley Additive exPlanations (SHAP). Data will also be analyzed to evaluate the
significance of data points over time, using attentional mechanisms to understand the importance of vital sign
changes over time. Primary human data sets, comprising true-positives, true-negatives, false-positives, and
false-negatives, will be tested using the algorithm to evaluate both its predictive and explainabilty capabilities.
Given that sepsis impacts 1.7 million Americans each year, the Patchd approach to explainable sepsis prediction
will address a large and growing market opportunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金